6508 ORAL CP-751, 871, an anti-IGF-IR antibody, in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC): A phase Ib/randomized phase II, ...

Details

Language :

English

ISSN :

13596349

Volume :

5

Issue :

4

Database :

Supplemental Index

Journal :

EJC Supplements

Publication Type :

Academic Journal

Accession number :

27457436

Full Text :

https://doi.org/10.1016/S1359-6349(07)71336-8